Real‐world performance of plasma p‐tau181 in a heterogeneous memory clinic cohort
Abstract Objective In light of clinical trials and disease‐modifying therapies, an early identification of patients at‐risk of developing Alzheimer's disease (AD) is crucial. Blood‐based biomarkers have shown promising results regarding the in vivo detection of the earliest neuropathological changes...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Wiley
2024-08-01
|
| Cyfres: | Annals of Clinical and Translational Neurology |
| Mynediad Ar-lein: | https://doi.org/10.1002/acn3.52116 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|